JPRN-jRCT2080223236未知1 期
Phase 1/2 study of NS-065/NCNP-01 in patients with Duchenne muscular dystrophy
IPPON SHINYAKU CO., LTD.0 个研究点目标入组 16 人开始时间: 2016年6月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 5age old 至 <= 17age old（—）
- 性别
- Male
入选标准
- •1) Ambulant or non-ambulant patient
- •2) Able to treat with skipping of exon 53
排除标准
- •Has participated in other clinical trial that might recover dystrophin protein by the readthrough or the exon-skipping therapy, and/or upregulate the dystrophin-associated proteins such as utrophin.
研究者
相似试验
招募中
1 期
A phase 1 study in patients with Fukuyama-type congenital muscular dystrophyFukuyama-type congenital muscular dystrophyJPRN-jRCT2031210252Toda Tatsushi12
未知
1 期
Phase 1 study of ONO-7056Solid tumorJPRN-jRCT2080221709ONO PHARMACEUTICAL CO.,LTD.36
招募中
1 期
A Phase I Clinical Study of NS-025 in Healthy SubjectsJPRN-jRCT2031220474Higashioka Masaya122
未知
2 期
ONO-2745 Phase II StudyPatients undergoing a surgery under general anesthesia requiring opiate analgesticsJPRN-jRCT2080221456ONO PHARMACEUTICAL CO.,LTD.90
未知
2 期
A Phase 2/3 Study of S-524101 in the Patients with Perennial Allergic RhinitisAllergic rhinitisJPRN-jRCT2080221872SHIONOGI & CO., LTD.